UBS AM’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.19M Buy
146,322
+32,867
+29% +$1.17M ﹤0.01% 1689
2025
Q1
$3.85M Sell
113,455
-22,983
-17% -$780K ﹤0.01% 1696
2024
Q4
$4.44M Buy
136,438
+36,181
+36% +$1.18M ﹤0.01% 1665
2024
Q3
$4.89M Sell
100,257
-6,276
-6% -$306K ﹤0.01% 1581
2024
Q2
$4.72M Sell
106,533
-223,790
-68% -$9.91M ﹤0.01% 1524
2024
Q1
$18.5M Buy
330,323
+29,917
+10% +$1.68M 0.01% 809
2023
Q4
$18.1M Buy
300,406
+38,001
+14% +$2.29M 0.01% 794
2023
Q3
$17.6M Buy
262,405
+47,947
+22% +$3.22M 0.01% 789
2023
Q2
$10.3M Hold
214,458
0.01% 963
2023
Q1
$10.3M Buy
214,458
+31,961
+18% +$1.54M 0.01% 963
2022
Q4
$9.11M Sell
182,497
-312,379
-63% -$15.6M ﹤0.01% 977
2022
Q3
$20.2M Buy
494,876
+9,737
+2% +$397K 0.01% 762
2022
Q2
$26.7M Buy
485,139
+320,007
+194% +$17.6M 0.01% 674
2022
Q1
$6M Buy
165,132
+44,798
+37% +$1.63M ﹤0.01% 1277
2021
Q4
$5.61M Buy
+120,334
New +$5.61M ﹤0.01% 1362
2020
Q3
Sell
-25,000
Closed -$1.06M 2501
2020
Q2
$1.06M Buy
+25,000
New +$1.06M ﹤0.01% 1775